Spine Biologics Market to Reach USD 2,629.6 Million By 2027 | CAGR: 3.9% | Reports And Data

Spine Biologics Market to Reach USD 2,629.6 Million By 2027 | CAGR: 3.9% | Reports And Data

PR Newswire

NEW YORK, Sept. 2, 2020

The increasing prevalence of spine disorders is one of the significant factors influencing the market growth.

Market Size – USD 1,928.9 Million in 2019, Market Growth - CAGR of 3.9%, Market Trends – Growing geriatric population

NEW YORK, Sept. 2, 2020 /PRNewswire/ -- The Global Spine Biologics Market is expected to reach USD 2,629.6 Million by 2027, according to a new report by Reports and Data. A growing occurrence of spine disorders is one of the significant factors influencing the growth of the spine biologics market. According to the World Health Organization (WHO), each year, globally, around 250,000 and 500,000 individuals suffer a spinal cord injury. Preventable causes, including road traffic accidents, falls, or violence, are the major contributors to the spinal cord injury, and individuals suffering from the condition are more likely to die prematurely as compared to healthy individuals with low and middle-income economies having the worst survival rates. Spinal cord injury is linked with a peril of occurrence of secondary conditions, which can be incapacitating and sometimes cost a person's life, such as urinary tract infections,  deep vein thrombosis, muscle spasms, pressure ulcers, osteoporosis, chronic pain, and respiratory complications.

Reports_And_Data_Logo

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/3495

As per the Global Health and Aging report published by the WHO (World Health Organization), the number of people aged 65 years or older is estimated to increase from a projected 524 million in 2010 to approximately 1.5 billion by 2050, with a significant percentage of increase in developing economies. Additionally, the number of people aged 65 years or older is anticipated to considerably surpass children younger than 5 years of age by 2050. Aging leads to the deterioration of facet joints resulting in several spinal disorders. Thus, the increasing prevalence of diseases in the growing geriatric population is likely to propel the growth of the spine biologics market in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the spine biologics industry. Demand for spine biologics materials has seen a decrease in demand, owing to mandatory lockdowns resulting movement restrictions to curb the spread of the infectious virus, especially in the older adults, who are at a higher risk of contracting the disease attributed to the weaker immune system. Further, lockdown restriction is causative of the disruption of the value chain, which, in turn, has an impact on the supply of biologics material required for the treatment of spinal deformities.

To identify the key trends in the industry, click on the link below: 
https://www.reportsanddata.com/report-detail/spine-biologics-market

Further key findings from the report suggest

Order Now: https://www.reportsanddata.com/checkout-form/3495

For the purpose of this report, Reports and Data has segmented the Global Spine Biologics Market on the basis of type, surgery type, end-user, and region:

Type Outlook (Revenue, USD Million; 2017-2027)

Surgery Type Outlook (Revenue, USD Million; 2017-2027)

End-User Outlook (Revenue, USD Million; 2017-2027)

Regional Outlook (Revenue, USD Million; 2017-2027)

Have a Look at Similar Research Reports:

Epigenetics Market - Increasing research activities and funding in the field of epigenetics, rising prevalence of target diseases/disorders, reduced sequencing time, and increasing geriatric population are key factors contributing to high CAGR of epigenetics market during the forecast period.

Biological Safety Testing Market - Rising incidences of chronic disorders is a major factor influencing market growth.

Computational Biology Market - Wide application of computational biology in genomics, epigenomics, proteomics, and meta-genomics to understand 3D protein structural analysis, protein-protein interactions, and gene sequencing

Bioinformatics Services Market - Growth in the application of technology in drug discovery and reduction in the cost of DNA sequencing is driving the market for Bioinformatics Services.

Consumer Genomics Market - Growth in genetic applications and reduction in the cost of sequencing is driving the market for consumer genomics.

Sterile Filtration Market - A growing demand for sterile filter from the pharmaceutical sector is one of the significant factors influencing the market growth.

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Read full Press Release at : https://www.reportsanddata.com/press-release/global-spine-biologics-market

Logo: https://mma.prnewswire.com/media/1009077/Reports_And_Data_Logo.jpg

Voltar noticias em Inglês